HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Günter Klöppel Selected Research

Synaptophysin

3/2022ENETS standardized (synoptic) reporting for neuroendocrine tumour pathology.
2/2022Neuroendocrine neoplasms of the pancreas: diagnosis and pitfalls.
2/2022Intra-abdominal EWSR1/FUS-CREM-rearranged malignant epithelioid neoplasms: two cases of an emerging aggressive entity with emphasis on misleading immunophenotype.
12/2021Mesenchymal/non-epithelial mimickers of neuroendocrine neoplasms with a focus on fusion gene-associated and SWI/SNF-deficient tumors.
10/2021Neuroendocrine Differentiation in Conventional Colorectal Adenocarcinomas: Incidental Finding or Prognostic Biomarker?
11/2020Do Canine Pancreatic Neuroendocrine Neoplasms Resemble Human Pancreatic Neuroendocrine Tumours? A Comparative Morphological and Immunohistochemical Investigation.
1/2017Somatostatin receptor expression related to TP53 and RB1 alterations in pancreatic and extrapancreatic neuroendocrine neoplasms with a Ki67-index above 20.
12/2011Pancreatic-type acinar cell carcinoma of the liver: a clinicopathologic study of four patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Günter Klöppel Research Topics

Disease

73Neoplasms (Cancer)
02/2022 - 05/2002
26Pancreatic Neoplasms (Pancreatic Cancer)
09/2018 - 12/2002
23Adenocarcinoma
10/2021 - 12/2002
18Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2020 - 11/2002
13Carcinoma (Carcinomatosis)
10/2021 - 05/2002
12Autoimmune Pancreatitis
05/2020 - 04/2007
7Chronic Pancreatitis
09/2018 - 11/2005
7Pancreatitis
10/2015 - 01/2003
6Insulinoma
11/2020 - 11/2002
6Carcinogenesis
11/2017 - 11/2006
6Gastrinoma
03/2016 - 11/2002
5Lymphatic Metastasis
01/2020 - 09/2003
5Hyperplasia
05/2015 - 01/2007
5Neoplasms, Cystic, Mucinous, and Serous
03/2015 - 02/2002
5Inflammation (Inflammations)
05/2009 - 11/2005
5Pancreatic Ductal Carcinoma
11/2006 - 12/2002
4Neuroendocrine Carcinoma
03/2022 - 03/2002
4Carcinoid Tumor (Carcinoid)
01/2018 - 11/2002
4Neoplasm Metastasis (Metastasis)
03/2016 - 10/2010
4Multiple Endocrine Neoplasia Type 1
05/2015 - 01/2007
4Fibrosis (Cirrhosis)
08/2012 - 07/2008
3Hypoglycemia (Reactive Hypoglycemia)
01/2018 - 02/2007
3Glucagonoma
04/2015 - 01/2009
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
05/2012 - 01/2007
3Cysts
01/2011 - 02/2002
3Necrosis
08/2006 - 12/2002
2Pancreatic Diseases (Pancreatic Disease)
01/2020 - 01/2009
2Hypoxia (Hypoxemia)
01/2019 - 12/2002
2Sclerosing Cholangitis
04/2018 - 03/2015
2Immunoglobulin G4-Related Disease
04/2018 - 09/2012
2Mucinous Adenocarcinoma (Mucinous Carcinoma)
12/2012 - 06/2003
2Large Cell Carcinoma
05/2009 - 05/2007
1Glandular and Epithelial Neoplasms (Neoplasms, Glandular)
02/2022
1Renal Cell Carcinoma (Grawitz Tumor)
02/2022
1Microsatellite Instability
09/2021
1Turcot syndrome
01/2021
1Pancreatic Intraductal Neoplasms
01/2021
1Pheochromocytoma
01/2020
1Paraganglioma (Paragangliomas)
01/2020
1Diabetes Mellitus
01/2018
1Coma (Comas)
01/2018
1Lung Neoplasms (Lung Cancer)
01/2018
1Olfactory Esthesioneuroblastoma (Esthesioneuroblastoma)
01/2018

Drug/Important Bio-Agent (IBA)

14Biological ProductsIBA
10/2021 - 05/2002
14Proteins (Proteins, Gene)FDA Link
01/2019 - 12/2002
11Glucagon (Glukagon)FDA Link
11/2020 - 05/2006
8SynaptophysinIBA
03/2022 - 12/2011
7Insulin (Novolin)FDA Link
11/2020 - 08/2003
6Chromogranin AIBA
03/2022 - 12/2011
6Biomarkers (Surrogate Marker)IBA
10/2021 - 04/2009
6SteroidsIBA
04/2018 - 08/2010
6Immunoglobulin G (IgG)IBA
04/2018 - 04/2007
6MucinsIBA
03/2017 - 02/2002
5Hormones (Hormone)IBA
11/2020 - 03/2009
5GastrinsIBA
03/2016 - 01/2007
5ProteomeIBA
01/2015 - 07/2005
4Keratins (Keratin)IBA
02/2022 - 05/2002
4Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2020 - 03/2008
4Transcription Factors (Transcription Factor)IBA
08/2011 - 06/2004
3RNA (Ribonucleic Acid)IBA
09/2021 - 09/2004
3Somatostatin Receptors (Somatostatin Receptor)IBA
01/2018 - 05/2014
3AntibodiesIBA
03/2017 - 08/2012
3EnzymesIBA
03/2017 - 01/2009
3Progesterone Receptors (Progesterone Receptor)IBA
01/2017 - 11/2006
3Coloring Agents (Dyes)IBA
01/2015 - 02/2007
3TrypsinIBA
12/2011 - 09/2004
3Lipase (Acid Lipase)FDA Link
12/2011 - 10/2006
3AmylasesFDA Link
12/2011 - 10/2006
3Interleukin-6 (Interleukin 6)IBA
04/2011 - 09/2006
3GelsIBA
08/2010 - 12/2004
3CytokinesIBA
07/2008 - 11/2005
3beta CateninIBA
09/2007 - 05/2004
3DNA (Deoxyribonucleic Acid)IBA
06/2007 - 09/2004
3Peptides (Polypeptides)IBA
05/2007 - 11/2002
3Messenger RNA (mRNA)IBA
05/2007 - 12/2002
3Codon (Codons)IBA
01/2005 - 05/2004
2somatostatin receptor 2IBA
11/2020 - 01/2018
2SERPIN-B5 (maspin)IBA
05/2020 - 09/2003
2Insulin-Like Growth Factor II (Somatomedin A)IBA
01/2018 - 05/2007
2Carcinoembryonic AntigenIBA
01/2018 - 12/2011
2somatostatin receptor 5IBA
01/2017 - 01/2013
2Glucagon Receptors (Glucagon Receptor)IBA
05/2015 - 04/2015
2Carrier Proteins (Binding Protein)IBA
01/2015 - 05/2007
2Serotonin (5 Hydroxytryptamine)IBA
08/2012 - 08/2003
2Cyclin D1IBA
07/2008 - 09/2007
2Transforming Growth Factor alpha (TGF-alpha)IBA
09/2007 - 11/2003
2VimentinIBA
06/2007 - 09/2002
2CeruletideIBA
05/2007 - 10/2006
2Protein Isoforms (Isoforms)IBA
08/2006 - 08/2003
2Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA
02/2006 - 08/2003
2NF-kappa B (NF-kB)IBA
02/2005 - 02/2004
1villinIBA
01/2021
1ChromatinIBA
11/2018
1GlypicansIBA
09/2018
1Formaldehyde (Formol)FDA Link
03/2018

Therapy/Procedure

18Therapeutics
09/2021 - 12/2007
6Drug Therapy (Chemotherapy)
01/2018 - 03/2002
3Pancreaticoduodenectomy
11/2018 - 07/2008
2Pancreatectomy
03/2009 - 11/2004
1Molecular Targeted Therapy
09/2021